drugset / Trial / NCT03857399
Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using Caspofungin
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is evaluating the efficacy and safety of generics caspofungin in the treatment of the patients with neutropenic and fever.Another purpose of this study is comparing the pharmacokinetic characteristics of generics caspofungin and original medicine(Cancidas®) for providing a basis for clinical rational administration.
Timeline
- Start
- 2018-09-17
- Primary completion
- 2019-12-31
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Caspofungin | Other / unclassified | 50 mg | Intravenous |